Abstract
Nanobiotechnology has very compelling role in vaccine development. Delivery system orientates toward less immunogenic minimal compositions and formulations that boost antigen effectiveness. Latest advancements in LNPs formulations as targeted vaccine delivery systems, like anticancer and nucleic acid therapeutics. Nanomedicine expel challenges and promote growth opportunities inareas, like biomedical imaging, nutraceuticals, biomedicine, gene technology, and basic sciences. The fundamental understanding regarding the in-vivo behavior of nanoparticles explored, which can perform as either a delivery system to enhance antigen processing and/or as an immunostimulant adjuvant to activate or enhance immunity. The utilization of nanoparticles in vaccine development allows targeted delivery, improved antigen stability and immunogenicity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Medical & Pharmaceutical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
